Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease

Pharmacological Reports

Volumn 68, Issue 4, 2016, Pages 816-826

  Uranga, José Antonio ^a,b   López Miranda, Visitación ^a,b,c   Lombó, Felipe ^d   Abalo, Raquel ^a,b,c  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

^c INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^d DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Crohn's disease; Functional foods; Inflammatory bowel disease; Nutraceuticals; Ulcerative colitis

Indexed keywords

AMINO ACID; NUTRACEUTICAL; OMEGA 3 FATTY ACID; PLANT MEDICINAL PRODUCT; PREBIOTIC AGENT; PROBIOTIC AGENT; VITAMIN D;

CAMPYLOBACTER JEJUNI; CLINICAL RESEARCH; FAT INTAKE; FUNCTIONAL FOOD; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LIPID STORAGE; NUTRIENT; OBESITY; REVIEW; WESTERN DIET; DIET; DIET THERAPY; DIETARY SUPPLEMENT;

DIET; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84971621876     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2016.05.002     Document Type: Review

References (165)

1. D. Owczarek, T. Rodacki, R. Domagała-Rodacka, D. Cibor, and T. Mach Diet and nutritional factors in inflammatory bowel diseases World J Gastroenterol 22 2016 895 905
2. R.B. Sartor Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis Nat Clin Pract Gastroenterol Hepatol 3 2006 390 407
3. S.M. Barbalho, A. Goulart Rde, K. Quesada, M.D. Bechara, and C. de Carvalho Ade Inflammatory bowel disease: can omega-3 fatty acids really help? Ann Gastroenterol 29 2016 37 43
4. H.S. De Souza, and C. Fiocchi Immunopathogenesis of IBD: current state of the art Nat Rev Gastroenterol Hepatol 13 2016 13 27
5. L.J. Dixon, A. Kabi, K.P. Nickerson, and C. McDonald Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis Inflamm Bowel Dis 21 2015 912 922
6. H. Zhang, C.A. Hu, J. Kovacs-Nolan, and Y. Mine Bioactive dietary peptides and amino acids in inflammatory bowel disease Amino Acids 47 2015 2127 2141
7. A.N. Ananthakrishnan, H. Khalili, and P.S. De Silva Higher dietary fiber intake is associated with lower risk of Crohn's disease but not ulcerative colitis - a prospective study Gastroenterology 142 Suppl 1 2010 S-148
8. D. Baumgart, and S. Carding Inflammatory bowel disease: cause and immunobiology Lancet 369 2007 1627 1640
9. A.N. Ananthakrishnan Epidemiology and risk factors for IBD Nat Rev Gastroenterol Hepatol 12 2015 205 217
10. S.C. Ng Epidemiology of inflammatory bowel disease: focus on Asia Best Pract Res Clin Gastroenterol 28 2014 363 372
11. A.E. M'Kooma Inflammatory bowel disease: an expanding global health problem Clin Med Insights Gastroenterol 6 2013 33 47
12. F.B. Hu Dietary pattern analysis: a new direction in nutritional epidemiology Curr Opin Lipidol 13 2002 3 9
13. C. Davis, J. Bryan, J. Hodgson, and K. Murphy Definition of the Mediterranean diet; a literature review Nutrients 7 2015 9139 9153
14. A. Jakubowski, E. Zagórowicz, E. Kraszewska, and W. Bartnik Rising hospitalization rates for inflammatory bowel disease in Poland Pol Arch Med Wewn 124 2014 180 190
15. S. Reif, I. Klein, F. Lubin, M. Farbstein, A. Hallak, and T. Gilat Pre-illness dietary factors in inflammatory bowel disease Gut 40 1997 754 760
16. M.G. Russel, L.G. Engels, J.W. Muris, C.B. Limonard, A. Volovics, R.J. Brummer, and et al. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors Eur J Gastroenterol Hepatol 10 1998 243 249
17. N. Sakamoto, S. Kono, K. Wakai, Y. Fukuda, M. Satomi, T. Shimoyama, and et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan Inflamm Bowel Dis 11 2005 154 163
18. S.S. Chan, R. Luben, F. van Schaik, B. Oldenburg, H.B. Bueno de Mesquita, G. Hallmans, and et al. Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis Inflamm Bowel Dis 20 2014 2013 2021
19. A. Racine, F. Carbonnel, S.S. Chan, A.R. Hart, H.B. Bueno de Mesquita, B. Oldenburg, and et al. Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC Study Inflamm Bowel Dis 22 2016 345 354
20. A.N. Ananthakrishnan, H. Khalili, G.G. Konijeti, L.M. Higuchi, P. de Silva, C.S. Fuchs, and et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease Gut 63 2014 776 784
21. A. Tjonneland, K. Overvad, M.M. Bergmann, G. Nagel, J. Linseisen, G. Hallmans, and et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study Gut 58 2009 1606 1611
22. J.M. Cooney, M.P. Barnett, D. Brewster, B. Knoch, W.C. McNabb, W.A. Laing, and et al. Proteomic analysis of colon tissue from interleukin-10 gene-deficient mice fed polyunsaturated fatty acids with comparison to transcriptomic analysis J Proteome Res 11 2012 1065 1077
23. L. Peyrin-Biroulet, J. Beisner, G. Wang, S. Nuding, S.T. Oommen, D. Kelly, and et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon Proc Natl Acad Sci USA 107 2010 8772 8777
24. J. Bassaganya-Riera, and R. Hontecillas Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease Curr Opin Clin Nutr Metab Care 13 2010 569 573
25. P. Ferreira, M. Cravo, C.S. Guerreiro, L. Tavares, P.M. Santos, and M. Brito Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity Clin Nutr 29 2010 819 823
26. P.S. De Silva, R. Luben, S.S. Shrestha, K.T. Khaw, and A.R. Hart Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries Eur J Gastroenterol Hepatol 26 2014 11 18
27. A.N. Ananthakrishnan, H. Khalili, G.G. Konijeti, L.M. Higuchi, P. de Silva, J.R. Korzenik, and et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis Gastroenterology 145 2013 970 977
28. B. Gustafson, A. Hammarstedt, C.X. Andersson, and U. Smith Inflamed adipose tissue a culprit underlying the metabolic syndrome and atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 2276 2283
29. G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J Clin Invest 95 1995 2409 2415
30. J.R. Greenfield, K. Samaras, A.B. Jenkins, P.J. Kelly, T.D. Spector, J.R. Gallimore, and et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences Circulation 109 2004 3022 3028
31. S.S.M. Chan, R. Luben, A. Olsen, A. Tjonneland, R. Kaaks, B. Teucher, and et al. Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European prospective cohort study (The IBD in EPIC Study) Am J Gastroenterol 108 2013 575 582
32. J. Dong, Y. Chen, Y. Tang, F. Xu, C. Yu, Y. Li, and et al. Body mass index is associated with inflammatory bowel disease: a systematic review and meta-analysis PLoS One 10 2015 e0144872
33. C. Fink, I. Karagiannides, K. Bakirtzi, and C. Pothoulakis Adipose tissue and inflammatory bowel disease pathogenesis Inflamm Bowel Dis 18 2012 1550 1557
34. F.L. Weakley, and R.B. Turnbull Recognition of regional ileitis in the operating room Dis Colon Rectum 14 1971 17 23
35. A.L. Sheehan, B.F. Warren, M.W. Gear, and N.A. Shepherd Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice Br J Surg 79 1992 955 958
36. A. Zulian, R. Cancello, G. Micheletto, D. Gentilini, L. Gilardini, P. Danelli, and et al. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? Gut 61 2012 86 94
37. E. González-Rey, P. Anderson, M.A. González, L. Rico, D. Büscher, and M. Delgado Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis Gut 58 2009 929 939
38. K. Majumder, Y. Mine, and J. Wu The potential of food-protein derived anti-inflammatory peptides against various chronic inflammatory diseases J Sci Food Agric 96 2016 2303 2311
39. L. Lih-Bordy, S.R. Powell, K.P. Collier, and G.M. Reddy Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease Dig Dis Sci 41 1996 2078 2086
40. Y.W. Li, and B. Li Characterization of structure-antioxidant activity relationship of peptides in free radical systems using QSAR models: key sequence positions and their amino acid properties J Theor Biol 318 2013 29 43
41. B. Laing, D.Y. Han, and L.R. Ferguson Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn's disease cohort Nutrients 5 2013 5046 5064
42. Y. Hou, C. Chu, T. Ko, C. Yeh, and S. Yeh Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium Eur J Nutr 52 2013 1089 1098
43. H. Zhang, J. Kovacs-Nolan, T. Kodera, Y. Eto, and Y. Mine γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor Biochim Biophys Acta 5 2015 792 804
44. M. Ortega-González, F. Capitán-Cañadas, P. Requena, B. Ocón, I. Romero-Calvo, C. Aranda, and et al. Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis Br J Nutr 7 2014 1202 1212
45. M.P. Utrilla, M.J. Peinado, R. Ruiz, A. Rodriguez-Nogales, F. Algieri, M.E. Rodriguez-Cabezas, and et al. Pea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis Mol Nutr Food Res 59 2015 807 819
46. A.M. Wolf, D. Wolf, H. Rumpold, A.R. Moschem, A. Kaser, P. Obrist, and et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease Clin Immunol 113 2004 47 55
47. C.J. Kim, J.A. Kovacs-Nolan, C. Yang, T. Archbold, M.Z. Fan, and Y. Mine L-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis J Nutr Biochem 21 2010 468 475
48. N.A. Kretzmann, H. Fillmann, J.L. Mauriz, C.A. Marroni, A. Marroni, J. Gonzalez-Gallego, and et al. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis Inflamm Bowel Dis 4 2008 1504 1513
49. H. Fillmann, N.A. Kretzmann, and B. San-Miguel Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat Toxicology 236 2007 217 226
50. M. Faure, C. Mettraux, D. Moennoz, J. Godin, J. Vuichoud, F. Rochat, and et al. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats J Nutr 136 2006 1558 1564
51. C.J. Kim, J. Kovacs-Nolan, C. Yang, T. Archbold, M.Z. Fan, and Y. Mine L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis Biochim Biophys Acta 1790 2009 1161 1169
52. S.A. Adibi The oligopeptide transporter (Pept-1) in human intestine: biology and function Gastroenterology 113 1997 332 340
53. D.O. Son, H. Satsu, Y. Kiso, M. Totsuka, and M. Shimizu Inhibitory effect of carnosine on interleukin-8 production in intestinal epithelial cells through translational regulation Cytokine 42 2008 265 276
54. J. Kovacs-Nolan, H. Zhang, M. Ibuki, T. Nakamori, K. Yoshiura, P.V. Turner, and et al. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation Biochim Biophys Acta 1820 2012 1753 1763
55. S.J. Quinn, C. Ye, R. Diaz, O. Kifor, M. Bai, P. Vassilev, and et al. The Ca2+-sensing receptor: a target for polyamines Am J Physiol Cell Physiol 273 1997 C1315 C1323
56. I.I. Pacheco, and R.J. MacLeod CaSR stimulates scretion of Wnt5a from colonic myofibroblasts to stimulate CDX2 and sucraseisomaltase using Ror2 on intestinal epithelia Am J Physiol Gastrointest Liver Physiol 295 2008 G748 G759
57. R.S. Bresalier Calcium, chemoprevention, and cancer: a small step forward (a long way to go) Gastroenterology 116 1999 1261 1263
58. S.C. Hebert, S. Cheng, and J. Geibel Functions and roles of the extracellular Ca2+-sensing receptor in the gastrointestinal tract Cell Calcium 35 2004 239 247
59. P.C. Calder Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance Biochim Biophys Acta 1851 2015 469 484
60. M. Tabbaa, M. Golubic, M.F. Roizen, and A.M. Bernstein Docosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome Nutrients 5 2013 3299 3310
61. S. Endres, R. Ghorbani, V.E. Kelley, K. Georgilis, G. Lonnemann, J.W. van der Meer, and et al. The effect of dietary supplementation with n-3 fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells N Engl J Med 320 1989 265 270
62. A. Belluzzi, S. Boschi, C. Brignola, A. Munarini, G. Cariani, and F. Miglio Polyunsaturated fatty acids and inflammatory bowel disease Am J Clin Nutr 71 1 Suppl 2000 339S 342S
63. M. Fisher, K.S. Upchurch, P.H. Levine, M.H. Johnson, C.H. Vaudreuil, A. Natale, and et al. Effect of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential Inflammation 10 1986 387 391
64. A.J. Wakefield, A.M. Sawyerr, A.P. Dhillon, R.M. Pittilo, P.M. Rowles, A.A. Lewis, and et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction Lancet 1 1989 1057 1062
65. M.J. Webberley, M.T. Hart, and V. Melikian Thromboembolism in inflammatory bowel disease: role of platelets Gut 34 1993 247 255
66. N. Nieto, M.I. Torres, A. Rios, and A. Gil Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis J Nutr 132 2002 11 19
67. C.A. Hudert, K.H. Weylandt, Y. Lu, J. Wang, S. Hong, A. Dignass, and et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis Proc Natl Acad Sci USA 103 2006 11276 11281
68. M. Arita, M. Yoshida, S. Hong, E. Tjonahen, J.N. Glickman, N.A. Petasis, and et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis Proc Natl Acad Sci USA 102 2005 7621 7626
69. D.S. Pearl, M. Masoodi, M. Eiden, J. Brümmer, D. Gullick, T.M. McKeever, and et al. Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity J Crohns Colitis 8 2014 70 79
70. D. Turner, T.H. Steinhart, and A.M. Griffiths Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis Cochrane Database Syst Rev 18 2007 CD006443
71. D. Turner, S.H. Zlotkin, P.S. Shah, and A.M. Griffiths Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease Cochrane Database Syst Rev 21 2009 CD006320
72. S. Meeker, A. Seamons, J. Paik, P.M. Treuting, T. Brabb, W.M. Grady, and et al. Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer Cancer Res 74 2014 4398 4408
73. A.N. Ananthakrishnan, S.C. Cheng, T. Cai, A. Cagan, V.S. Gainer, P. Szolovits, and et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases Clin Gastroenterol Hepatol 12 2014 821 827
74. S. Shivananda, J. Lennard-Jones, R. Logan, N. Fear, A. Price, L. Carpenter, and et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD) Gut 39 1996 690 697
75. M. O'Sullivan Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? Proc Nutr Soc 74 2015 5 12
76. V.P. Mouli, and A.N. Ananthakrishnan Review article: vitamin D and inflammatory bowel diseases Aliment Pharmacol Ther 39 2014 125 136
77. D. Waśko-Czopnik, and L. Paradowski The influence of deficiencies of essential trace elements and vitamins on the course of Crohn's disease Adv Clin Exp Med 21 2012 5 11
78. M. Garg, J.S. Lubel, M.P. Sparrow, S.G. Holt, and P.R. Gibson Review article: vitamin D and inflammatory bowel disease-established concepts and future directions Aliment Pharmacol Ther 36 2012 324 344
79. A. Ulitsky, A.N. Ananthakrishnan, A. Naik, S. Skaros, Y. Zadvornova, D.G. Binion, and et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life JPEN J Parenter Enteral Nutr 35 2011 308 316
80. F.K. Ghishan, and P.R. Kiela Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases Am J Physiol Gastrointest Liver Physiol 300 2011 G191 G201
81. Y. Lee, M. Kim, K. Choi, J. Kim, W. Bae, S. Kim, and et al. Relationship between inflammation biomarkers, antioxidant vitamins, and bone mineral density in patients with metabolic syndrome Nutr Res Pract 5 2011 150 156
82. G. Laverny, G. Penna, S. Vetrano, C. Correale, M. Nebuloni, S. Danese, and et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease Immunol Lett 131 2010 49 58
83. S.W. Chen, P.Y. Wang, J. Zhu, G.W. Chen, J.L. Zhang, Z.Y. Chen, and et al. Protective effect of 1,25-dihydroxyvitamin D3 on lipopolysaccharide-induced intestinal epithelial tight junction injury in Caco-2 cell monolayers Inflammation 38 2015 375 383
84. J. Schauber, D. Rieger, F. Weiler, J. Wehkamp, M. Eck, K. Fellermann, and et al. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases Eur J Gastroenterol Hepatol 18 2006 615 621
85. M. Verway, M.A. Behr, and J.H. White Vitamin D, NOD2, autophagy and Crohn's disease Expert Rev Clin Immunol 6 2010 505 508
86. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
87. T. Raftery, and M. O'Sullivan Optimal vitamin D levels in Crohn's disease: a review Proc Nutr Soc 74 2015 56 66
88. K.M. Reich, R.N. Fedorak, K. Madsen, and K.I. Kroeker Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review World J Gastroenterol 20 2014 4934 4947
89. H.S. Cross, T. Nittke, and E. Kallay Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer Mol Cell Endocrinol 347 2011 70 79
90. A.N. Ananthakrishnan, A. Cagan, V.S. Gainer, T. Cai, S.C. Cheng, G. Savova, and et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease Inflamm Bowel Dis 19 2013 1921 1927
91. Z.A. Zator, S.M. Cantu, G.G. Konijeti, D.D. Nguyen, J. Sauk, V. Yajnik, and et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases JPEN J Parenter Enteral Nutr 38 2014 385 391
92. T. Hlavaty, A. Krajcovicova, and J. Payer Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? J Crohns Colitis 9 2015 198 209
93. L. Biedermann, J. Mwinyi, M. Scharl, P. Frei, J. Zeitz, G.A. Kullak-Ublick, and et al. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis-an open pilot study J Crohns Colitis 7 2013 271 279
94. M. Joo, H.S. Kim, T.H. Kwon, A. Palikhe, T.S. Zaw, J.H. Jeong, and et al. Anti-inflammatory effects of flavonoids on TNBS-induced colitis of rats Korean J Physiol Pharmacol 19 2015 43 50
95. H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, A. Andoh, and et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial Clin Gastroenterol Hepatol 4 2006 1502 1506
96. H.M. Arafa, R.A. Hemeida, A.I. El-Bahrawy, and F.M. Hamada Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model Food Chem Toxicol 47 2009 1311 1317
97. T. Unno, M. Sakuma, and S. Mitsuhashi Effect of dietary supplementation of (-)-epigallocatechin gallate on gut microbiota and biomarkers of colonic fermentation in rats J Nutr Sci Vitaminol (Tokyo) 60 2014 213 219
98. H. Martin, E.J. Burgess, W.A. Smith, T.K. McGhie, J.M. Cooney, R.C. Lunken, and et al. JAK2 and AMP-kinase inhibition in vitro by food extracts, fractions and purified phytochemicals Food Funct 6 2015 305 312
99. N. Ahmed Nasef, S. Mehta, and L.R. Ferguson Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case Front Genet 5 2014 64 10.3389/fgene.2014.00064
100. G. Cammarota, G. Ianiro, S. Bibbò, and A. Gasbarrini Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 9 2014 365 373
101. P. Marteau Therapy: probiotic-enriched artichokes for abdominal discomfort Nat Rev Gastroenterol Hepatol 9 2012 251 252
102. D.A. Burke, and A.T. Axon Ulcerative colitis and Escherichia coli with adhesive properties J Clin Pathol 40 1987 782 786
103. C. Favier, C. Neut, C. Mizon, A. Cortot, J.F. Colombel, and J. Mizon Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease Dig Dis Sci 42 1997 817 822
104. H.A. Malchow Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 25 1997 653 658
105. P. Gupta, H. Andrew, B.S. Kirschner, and S. Guandalini Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study J Pediatr Gastroenterol Nutr 31 2000 453 457
106. C.S. Ardita, J.W. Mercante, Y.M. Kwon, L. Luo, M.E. Crawford, D.N. Powell, and et al. Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses Appl Environ Microbiol 80 2014 5068 5077
107. T. Takamura, D. Harama, S. Fukumoto, Y. Nakamura, N. Shimokawa, K. Ishimaru, and et al. Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis Immunol Cell Biol 89 2011 817 822
108. M. Guslandi, G. Mezzi, M. Sorghi, and P.A. Testoni Saccharomyces boulardii in maintenance treatment of Crohn's disease Dig Dis Sci 45 2000 1462 1464
109. A. Bourreille, G. Cadiot, G. Le Dreau, D. Laharie, L. Beaugerie, J.L. Dupas, and et al. Saccharomyces boulardii does not prevent relapse of Crohn's disease. FLORABEST Study Group Clin Gastroenterol Hepatol 11 2013 982 987
110. H. Ishikawa, I. Akedo, Y. Umesaki, R. Tanaka, A. Imaoka, and T. Otani Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis J Am Coll Nutr 22 2003 56 63
111. N. Osman, D. Adawi, G. Molin, S. Ahrne, A. Berggren, and B. Jeppsson Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats BMC Gastroenterol 6 2006 31
112. A. Camelo-Castillo, A. Benítez-Páez, P. Belda-Ferre, R. Cabrera-Rubio, and A. Mira Streptococcus dentisani sp. nov., a novel member of the mitis group Int J Syst Evol Microbiol 64 2014 60 65
113. G.C. van Zanten, A. Knudsen, H. Röytiö, S. Forssten, M. Lawther, A. Blennow, and et al. The effect of selected symbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon PLoS One 7 2012 e47212
114. J.F. Valenzuela, L. Pinuer, A.G. Cancino, and R.B. Yáñez Effect of pH and dilution rate on specific production rate of extra cellular metabolites by Lactobacillus salivarius UCO-979C in continuous culture Appl Microbiol Biotechnol 99 2015 6417 6429
115. A. Cruz-Guerrero, H. Hernández-Sánchez, G. Rodríguez-Serrano, L. Gómez-Ruiz, M. García-Garibay, and I. Figueroa-González Commercial probiotic bacteria and prebiotic carbohydrates: a fundamental study on prebiotics uptake, antimicrobials production and inhibition of pathogens J Sci Food Agric 94 2014 2246 2252
116. D.R. Mack, S. Ahrne, L. Hyde, S. Wei, and M.A. Hollingsworth Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro Gut 52 2003 827 833
117. A. García-Lafuente, M. Antolín, F. Guarner, E. Crespo, and J.R. Malagelada Modulation of colonic barrier function by the composition of the commensal flora in the rat Gut 48 2001 503 507
118. D. Srutkova, M. Schwarzer, T. Hudcovic, Z. Zakostelska, V. Drab, A. Spanova, and et al. Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute DSS-induced colitis in strictly strain-specific manner PLoS One 10 2015 e0134050
119. J.H. Park, J.I. Um, B.J. Lee, J.S. Goh, S.Y. Park, W.S. Kim, and et al. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production Cell Immunol 219 2002 22 27
120. T. Kawahara, T. Takahashi, K. Oishi, H. Tanaka, M. Masuda, S. Takahashi, and et al. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model Microbiol Immunol 59 2015 1 12
121. K. Yoda, F. He, M. Kawase, K. Miyazawa, and M. Hiramatsu Oral administration of Lactobacillus gasseri TMC0356 stimulates peritoneal macrophages and attenuates general symptoms caused by enteropathogenic Escherichia coli infection J Microbiol Immunol Infect 47 2014 81 86
122. S.K. Mazmanian, J.L. Round, and D.L. Kasper A microbial symbiosis factor prevents intestinal inflammatory disease Nature 453 7195 2008 620 625
123. S. Hapfelmeier, M.A. Lawson, E. Slack, J.K. Kirundi, M. Stoel, M. Heikenwalder, and et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses Science 328 5986 2010 1705 1709
124. Y. Okada, Y. Tsuzuki, K. Narimatsu, H. Sato, T. Ueda, H. Hozumi, and et al. 1,4-Dihydroxy-2-naphthoic acid from Propionibacterium freudenreichii reduces inflammation in interleukin-10-deficient mice with colitis by suppressing macrophage-derived proinflammatory cytokines J Leukoc Biol 94 2013 473 480
125. I. González-Rodríguez, B. Sánchez, L. Ruiz, F. Turroni, M. Ventura, P. Ruas-Madiedo, and et al. Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation Appl Environ Microbiol 78 2012 3992 3998
126. J.B. Ewaschuk, H. Diaz, L. Meddings, B. Diederichs, A. Dmytrash, J. Backer, and et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function Am J Physiol Gastrointest Liver Physiol 295 2008 G1025 G1034
127. E. Macho Fernández, B. Pot, and C. Grangette Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors? Gut Microbes 2 2011 280 286
128. M. Muraca, L. Putignani, A. Fierabracci, A. Teti, and G. Perilongo Gut microbiota-derived outer membrane vesicles: under-recognized major players in health and disease? Discov Med 19 2015 343 348
129. A. Elmi, F. Nasher, H. Jagatia, O. Gundogdu, M. Bajaj-Elliott, B.W. Wren, and et al. Campylobacter jejuni outer membrane vesicle-associated proteolytic activity promotes bacterial invasion by mediating cleavage of intestinal epithelial cell E-cadherin and occludin Cell Microbiol 18 2016 561 572
130. C.S. Kang, M. Ban, E.J. Choi, H.G. Moon, J.S. Jeon, D.K. Kim, and et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis PLoS One 8 2013 e76520
131. J. Marcinkiewicz, M. Ciszek, M. Bobek, M. Strus, P.B. Heczko, M. Kurnyta, and et al. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria Int J Exp Pathol 88 2007 155 164
132. A. Hevia, S. Delgado, B. Sánchez, and A. Margolles Molecular players involved in the interaction between beneficial bacteria and the immune system Front Microbiol 6 2015 1285
133. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci USA 104 2007 13780 13785
134. R. Kotlowski, C.N. Bernstein, S. Sepehri, and D.O. Krause High prevalence of Escherichia coli belonging to the B2 + D phylogenetic group in inflammatory bowel disease Gut 56 2007 669 675
135. D. Laubitz, C.A. Harrison, M.T. Midura-Kiela, R. Ramalingam, C.B. Larmonier, J.H. Chase, and et al. Reduced epithelial Na+/H+ exchange drives gut microbial dysbiosis and promotes inflammatory response in T cell-mediated murine colitis PLoS One 11 4 2016 e0152044
136. M. Economou, T.A. Trikalinos, K.T. Loizou, E.V. Tsianos, and J.P. Ioannidis Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis Am J Gastroenterol 99 2004 2393 2404
137. K.S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Núñez, and et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307 2005 731 734
138. C.C. Lim, L.R. Ferguson, and G.W. Tannock Dietary fibres as "prebiotics": implications for colorectal cancer Mol Nutr Food Res 49 2005 609 619
139. M.B. Roberfroid Prebiotics and synbiotics: concepts and nutritional properties Br J Nutr 80 1998 S197 S202
140. F. Capitán-Cañadas, B. Ocón, C.J. Aranda, A. Anzola, M.D. Suárez, A. Zarzuelo, and et al. Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice Eur J Nutr 2015 10.1007/s00394-015-0962-6
141. C. Cherbut, C. Michel, and G. Lecannu The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats J Nutr 133 2003 21 27
142. F. Hoentjen, G.W. Welling, H.J. Harmsen, X. Zhang, J. Snart, G.W. Tannock, and et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation Inflamm Bowel Dis 11 2005 977 985
143. F. Lara-Villoslada, E. Debras, A. Nieto, A. Concha, J. Galvez, E. Lopez-Huertas, and et al. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis Clin Nutr 25 2005 477 488
144. M.E. Johansson, H. Sjövall, and G.C. Hansson The gastrointestinal mucus system in health and disease Nat Rev Gastroenterol Hepatol 10 2013 352 361
145. M.E. Johansson, J.K. Gustafsson, J. Holmén-Larsson, K.S. Jabbar, L. Xia, H. Xu, and et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis Gut 63 2014 281 291
146. N.M. Schwerbrock, M.K. Makkink, M. van der Sluis, H.A. Büller, A.W. Einerhand, R.B. Sartor, and et al. Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria Inflamm Bowel Dis 10 2004 811 823
147. G. Cresci, L.E. Nagy, and V. Ganapathy Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury JPEN J Parenter Enteral Nutr 37 2013 763 774
148. E. Richman, and J.M. Rhodes Review article: evidence-based dietary advice for patients with inflammatory bowel disease Aliment Pharmacol Ther 38 2013 1156 1171
149. J.M. Fell Control of systemic and local inflammation with transforming growth factor beta containing formulas J Parenter Enteral Nutr 29 2005 S126 S128
150. J.K. Triantafillidis, C. Vagianos, and A.E. Papalois The role of enteral nutrition in patients with inflammatory bowel disease: current aspects Biomed Res Int 2015 2015 197167
151. J.K. Hou, D. Lee, and J. Lewis Diet and inflammatory bowel disease: review of patient-targeted recommendations Clin Gastroenterol Hepatol 12 2014 1592 1600
152. A. Kornbluth, D.B. Sachar, and Practice Parameters Committee of the American College of Gastroenterology Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee Am J Gastroenterol 105 2010 501 523 quiz 524
153. G.R. Lichtenstein, S.B. Hanauer, W.J. Sandborn, and Practice Parameters Committee of American College of Gastroenterology Management of Crohn's disease in adults Am J Gastroenterol 104 2009 465 483 quiz 464, 484
154. D. Turner, A. Levine, J.C. Escher, A.M. Griffiths, R.K. Russell, A. Dignass, and et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines J Pediatr Gastroenterol Nutr 55 2012 340 361
155. National Institute for Health and Clinical Excellence Crohn's disease: Management in adults, children and young people 2012 October National Clinical Guideline Centre
156. L.R. Ferguson Nutritional modulation of gene expression: might this be of benefit to individuals with Crohn's disease? Front Immunol 6 2015 467
157. E. Cabré, and E. Domènech Impact of environmental and dietary factors on the course of inflammatory bowel disease World J Gastroenterol 18 2012 3814 3822
158. C.H. Song, C.M. Vadheim, W.J. Snape, and D.C. Heiner Antibodies in patients with inflammatory bowel disease and the apparent influence of medications J Clin Lab Immunol 46 1995 143 154
159. P. Nijeboer, H.J. Bontkes, C.J. Mulder, and G. Bouma Non-celiac gluten sensitivity. Is it in the gluten or the grain? J Gastrointestin Liver Dis 22 2013 435 440
160. G. Casella, C. Di Bella, M. Salemme, V. Villanacci, E. Antonelli, V. Baldini, and et al. Celiac disease, non-celiac gluten sensitivity and inflammatory bowel disease Minerva Gastroenterol Dietol 61 2015 267 271
161. H.H. Herfarth, C.F. Martin, R.S. Sandler, M.D. Kappelman, and M.D. Long Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases Inflamm Bowel Dis 20 2014 1194 1197
162. I. Aziz, M. Hadjivassiliou, and D.S. Sanders The spectrum of noncoeliac gluten sensitivity Nat Rev Gastroenterol Hepatol 12 2015 516 526
163. J.G. Muir, and P.R. Gibson The low FODMAP diet for treatment of irritable bowel syndrome and other gastrointestinal disorders Gastroenterol Hepatol (NY) 9 2013 450 452
164. C.F. Donnellan, L.H. Yann, and S. Lal Nutritional management of Crohn's disease Therap Adv Gastroenterol 6 2013 231 242
165. R.A. Rastall, and G.R. Gibson Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health Curr Opin Biotechnol 32 2015 42 46